SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 100 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $27,208,000 | -15.3% | 1,843,388 | -15.0% | 5.07% | -46.9% |
| Q2 2020 | $32,140,000 | +35.1% | 2,168,691 | 0.0% | 9.56% | -33.9% |
| Q1 2020 | $23,791,000 | +24.9% | 2,168,691 | 0.0% | 14.47% | +72.7% |
| Q4 2019 | $19,041,000 | +17.5% | 2,168,691 | 0.0% | 8.38% | +20.9% |
| Q3 2019 | $16,200,000 | -19.8% | 2,168,691 | 0.0% | 6.93% | -15.0% |
| Q2 2019 | $20,191,000 | +77.3% | 2,168,691 | 0.0% | 8.16% | +73.8% |
| Q1 2019 | $11,386,000 | +18.0% | 2,168,691 | 0.0% | 4.70% | -42.5% |
| Q4 2018 | $9,651,000 | -44.9% | 2,168,691 | 0.0% | 8.17% | -31.2% |
| Q3 2018 | $17,523,000 | +15.1% | 2,168,691 | 0.0% | 11.86% | +101.2% |
| Q2 2018 | $15,224,000 | -50.7% | 2,168,691 | 0.0% | 5.90% | -50.4% |
| Q1 2018 | $30,860,000 | +62.4% | 2,168,691 | 0.0% | 11.89% | +56.1% |
| Q4 2017 | $18,998,000 | -25.1% | 2,168,691 | 0.0% | 7.61% | -38.5% |
| Q3 2017 | $25,374,000 | -16.2% | 2,168,691 | 0.0% | 12.38% | -5.9% |
| Q2 2017 | $30,297,000 | +1.8% | 2,168,691 | 0.0% | 13.16% | -8.0% |
| Q1 2017 | $29,754,000 | +91.3% | 2,168,691 | 0.0% | 14.31% | +95.0% |
| Q4 2016 | $15,550,000 | -52.7% | 2,168,691 | 0.0% | 7.34% | -31.8% |
| Q3 2016 | $32,877,000 | +53.9% | 2,168,691 | 0.0% | 10.77% | +55.4% |
| Q2 2016 | $21,362,000 | -26.0% | 2,168,691 | 0.0% | 6.93% | -22.6% |
| Q1 2016 | $28,887,000 | – | 2,168,691 | – | 8.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |